We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

558 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2016 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $37.9M | Put options by funds: $23.6M

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

22% more funds holding in top 10

Funds holding in top 10: 9 → 11 (+2)

21% more capital invested

Capital invested by funds: $9.29B → $11.2B (+$1.95B)

3.82% more ownership

Funds ownership: 93.85% → 97.66% (+3.8%)

4% more repeat investments, than reductions

Existing positions increased: 205 | Existing positions reduced: 197

0% more funds holding

Funds holding: 557 → 558 (+1)

Holders
558
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
14.89%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.29%
New
52
Increased
205
Reduced
197
Closed
41
Calls
$37.9M
Puts
$23.6M
Net Calls
+$14.3M
Net Calls Change
+$1.29M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$685M
2
Victory Capital Management
Victory Capital Management
Texas
+$95.2M
3
American Century Companies
American Century Companies
Missouri
+$77.8M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$74.6M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$54.9M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$229M
2
Royal London Asset Management
Royal London Asset Management
United Kingdom
-$188M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$70.2M
4
HM
HealthCor Management
New York
-$53.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$52.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCS
451
Levin Capital Strategies
New York
$205K +$192K +2,520 New
KeyBank National Association
452
KeyBank National Association
Ohio
$203K +$190K +2,493 New
MMPW
453
Mitchell McLeod Pugh & Williams
Alabama
$202K +$189K +2,480 New
OC
454
Oakworth Capital
Alabama
$201K +$121K +1,594 +157%
Pacer Advisors
455
Pacer Advisors
Pennsylvania
$200K +$2.74K +36 +1%
BMM
456
Buffington Mohr McNeal
Idaho
$195K – – –
CTC
457
Central Trust Company
Missouri
$189K -$1.9K -25 -1%
MFS
458
MSI Financial Services
Massachusetts
$188K -$990 -13 -0.6%
FMLI
459
Fukoku Mutual Life Insurance
Japan
$179K -$15.2K -200 -8%
BEAM
460
Baker Ellis Asset Management
Washington
$175K – – –
MAM
461
Mizuho Asset Management
Japan
$164K +$74.8K +982 +95%
HSA
462
Hussman Strategic Advisors
Maryland
$163K – – –
FWM
463
Focused Wealth Management
New York
$163K +$152K +2,000 New
MME
464
Meag Munich Ergo
Germany
$161K – – –
Creative Planning
465
Creative Planning
Kansas
$161K +$17.8K +234 +13%
IIC
466
Integrated Investment Consultants
Michigan
$152K +$13.4K +176 +10%
VIM
467
Veritas Investment Management
United Kingdom
$147K – – –
WRM
468
Westport Resources Management
Connecticut
$147K – – –
CFG
469
Citizens Financial Group
Rhode Island
$136K – – –
PRS
470
Pinkerton Retirement Specialists
Idaho
$134K +$112K +1,466 +792%
LWCFA
471
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$122K – – –
FANJ
472
Financial Architects (New Jersey)
New Jersey
$120K +$6.78K +89 +6%
EWM
473
Endurance Wealth Management
Rhode Island
$90K -$9.52K -125 -10%
FNBT
474
FineMark National Bank & Trust
Florida
$88K -$24.7K -324 -23%
MCA
475
Mercer Capital Advisers
New Jersey
$88K – – –
17 18
19
20 21

DGX Hedge Fund Activity: Q2 2016 in Review

558 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2016, worth a combined $11.2B — up 21% from $9.29B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new DGX positions and 41 closed out — a net gain of 11 holders — while 205 added to existing stakes and 197 trimmed.

The largest buyer was Macquarie Group, adding an estimated $685M. The largest seller was T. Rowe Price Associates, cutting an estimated $229M.

  • 558 institutional investors held Quest Diagnostics (DGX) as of Q2 2016, up from 557 in Q1 2016.
  • Funds reported $11.2B of Quest Diagnostics stock for Q2 2016, up 21% quarter-over-quarter.
  • 52 funds opened new Quest Diagnostics positions in Q2 2016 and 41 closed out, a net change of +11 holders.
  • The largest Quest Diagnostics buyer in Q2 2016 was Macquarie Group, an estimated $685M added.
  • The largest Quest Diagnostics seller in Q2 2016 was T. Rowe Price Associates, an estimated $229M sold.

Based on aggregated 13F filings for Q2 2016.